Authors:
TOTEMEYER S
BOOTH NA
NICHOLS WW
DUNBAR B
BOOTH IR
Citation: S. Totemeyer et al., FROM FAMINE TO FEAST - THE ROLE OF METHYLGLYOXAL PRODUCTION IN ESCHERICHIA-COLI, Molecular microbiology, 27(3), 1998, pp. 553-562
Citation: Aj. Simpson et al., DOES CHRONIC SMOKING INFLUENCE FIBRINOLYTIC POTENTIAL IN TYPE-1 DIABETES-MELLITUS, Diabetic medicine, 15(8), 1998, pp. 683-687
Citation: H. Ritchie et Na. Booth, THE DISTRIBUTION OF THE SECRETED AND INTRACELLULAR FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) IN HUMAN PERIPHERAL-BLOOD MONOCYTES IS MODULATED BY SERUM, Thrombosis and haemostasis, 79(4), 1998, pp. 813-817
Authors:
BOOTH NA
DAVIS R
WOODRUFF DP
CHRYSOSTOMOU D
MCCABE T
LLOYD DR
SCHAFF O
FERNANDEZ V
BAU S
SCHINDLER KM
LINDSAY R
HOEFT JT
TERBORG R
BAUMGARTEL P
BRADSHAW AM
Citation: Na. Booth et al., CN COORDINATION IN THE ADSORPTION SYSTEM NI(110)C(2X2)-CN - AN UNEXPECTED GEOMETRY, Surface science, 416(3), 1998, pp. 448-459
Citation: H. Ritchie et Na. Booth, SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 BY HUMAN PERIPHERAL-BLOOD MONOCYTES OCCURS VIA AN ENDOPLASMIC RETICULUM-GOLGI-INDEPENDENT PATHWAY, Experimental cell research, 242(2), 1998, pp. 439-450
Authors:
CROLL AM
ROBBIE LA
ADEY G
BOOTH NA
BENNETT B
Citation: Am. Croll et al., PLATELET AND PLASMA PAI-1 ANTIGEN AND ACTIVITY IN PATIENTS AT RISK OFTHROMBOSIS - STUDIES ON CORONARY-ARTERY DISEASE AND ESSENTIAL THROMBOCYTHEMIA, British Journal of Haematology, 101, 1998, pp. 219-219
Authors:
AERTGEERTS K
DERANTER CJ
BOOTH NA
DECLERCK PJ
Citation: K. Aertgeerts et al., RATIONAL DESIGN OF COMPLEX-FORMATION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND ITS TARGET PROTEINASES, Journal of structural biology, 118(3), 1997, pp. 236-242
Citation: Hm. Wilson et al., OPPOSING EFFECTS OF INTERLEUKIN-1 AND TRANSFORMING GROWTH-FACTOR-BETAON THE REGULATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 EXPRESSION BY HUMAN MESANGIAL CELLS, Experimental nephrology, 5(3), 1997, pp. 233-238
Citation: H. Ritchie et Na. Booth, SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) BY MONOCYTES OCCURS VIA AN ER-GOLGI INDEPENDENT PATHWAY, Thrombosis and haemostasis, 1997, pp. 2365-2365
Citation: H. Ritchie et al., REGULATION, LOCATION AND ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) IN PERIPHERAL-BLOOD MONOCYTES, MACROPHAGES AND FOAM CELLS, Thrombosis and haemostasis, 77(6), 1997, pp. 1168-1173
Citation: La. Robbie et al., THROMBI FORMED IN A CHANDLER LOOP MIMIC HUMAN ARTERIAL THROMBI IN STRUCTURE AND PAI-1 CONTENT AND DISTRIBUTION, Thrombosis and haemostasis, 77(3), 1997, pp. 510-515
Authors:
BOOTH NA
DAVIS R
TOOMES R
WOODRUFF DP
HIRSCHMUGL C
SCHINDLER KM
SCHAFF O
FERNANDEZ V
THEOBALD A
HOFMANN P
LINDSAY R
GIESSEL T
BAUMGARTEL P
BRADSHAW AM
Citation: Na. Booth et al., STRUCTURE DETERMINATION OF AMMONIA ON CU(110) - A LOW-SYMMETRY ADSORPTION SITE, Surface science, 387(1-3), 1997, pp. 152-159
Citation: Hm. Wilson et al., EFFECT OF ANGIOTENSIN-II ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 PRODUCTION BY CULTURED HUMAN MESANGIAL CELLS, Nephron, 77(2), 1997, pp. 197-204
Citation: Aj. Simpson et al., THE EFFECTS OF CHRONIC SMOKING ON THE FIBRINOLYTIC POTENTIAL OF PLASMA AND PLATELETS, British Journal of Haematology, 97(1), 1997, pp. 208-213
Citation: La. Robbie et al., INHIBITORS OF FIBRINOLYSIS ARE ELEVATED IN ATHEROSCLEROTIC PLAQUE, Arteriosclerosis, thrombosis, and vascular biology, 16(4), 1996, pp. 539-545
Citation: Hm. Wilson et al., INTERLEUKIN-1-BETA UP-REGULATES THE PLASMINOGEN-ACTIVATOR PLASMIN SYSTEM IN HUMAN MESANGIAL CELLS, Kidney international, 49(4), 1996, pp. 1097-1104
Authors:
WOODRUFF DP
DAVIS R
BOOTH NA
BRADSHAW AM
HIRSCHMUGL CJ
SCHINDLER KM
SCHAFF O
FERNANDEZ V
THEOBALD A
HOFMANN P
FRITZSCHE V
Citation: Dp. Woodruff et al., AN INTEGRATED APPROACH TO ADSORBATE STRUCTURE DETERMINATION USING PHOTOELECTRON DIFFRACTION - DIRECT IMAGING AND QUANTITATIVE SIMULATION, Surface science, 358(1-3), 1996, pp. 19-27